Drugs grown in live cells are hard to replicate. But policy changes can help accelerate the process. iologic drugs are one of this century’s great medical triumphs. They’ve reshaped the treatment of diverse and debilitating diseases from cancer to multiple sclerosis to heart attacks. They’re also one of the fastest-growing segments of